Introduction: The Gram-Negative bacteria, particularly carbapenem-resistant strains (CR-GNB), pose a global health threat due to high morbidity and mortality. Detecting carbapenemase-encoding genes is essential for understanding their spread in hospital environments. This study investigated environmental colonization by CR-GNB in Ethiopian hospitals, including genetic characterization of resistance genes. Methodology: A cross-sectional study analyzed 103 environmental GNB isolates collected from inanimate surfaces at Tikur Anbessa Specialized Hospital (TASH) and ALERT Hospital (June–September 2021). Conventional microbiological methods identified the isolates, and antimicrobial susceptibility was tested using the Kirby-Bauer disk diffusion method. Carbapenemase production was screened using the Modified Hodge test (MHT) and combined disk test (CDT). Resistance genes (blaKPC, blaNDM, blaOXA-48) were detected via PCR in isolates with reduced meropenem susceptibility. Results: The predominant GNB were Acinetobacter baumannii (47%), Pseudomonas aeruginosa (33%), and E. coli (12%). Among 103 isolates, 62% showed reduced meropenem susceptibility. The most common CR-GNB was Acinetobacter baumannii (37.5%), followed by E. coli (18.8%) and Klebsiella pneumoniae (12.5%). Carbapenemase production was detected in 41.7% of isolates via PCR, with blaNDM being the most common (43 isolates). Linens (26.4%) and beds (21.4%) had the highest contamination rates. Most carbapenemase-producing isolates were multidrug-resistant (MDR). Conclusions: The presence of blaNDM and blaKPC genes highlights hospital surfaces as reservoirs for resistance genes, contributing to healthcare-associated infections. Routine surveillance and early detection of carbapenemase producers are crucial for infection control and antimicrobial resistance management.
Carbapenem-resistant Enterobacterales (CRE), particularly carbapenemase-producing CRE (CP-CRE) are a growing global threat in health care. Intestinal colonization increases infection risk and facilitates transmission in the hospital. We aimed to determine intestinal colonization of CRE and CP-CRE among hospitalized patients in Addis Ababa, Ethiopia. A longitudinal study was conducted on 165 patients from February 2023 to April 2024 at Tikur Anbessa Specialized Hospital. Microbial identification and antimicrobial susceptibility testing were done using VITEK 2. Carbapenemase production was confirmed using the modified carbapenem inactivation method, and Polymerase Chain Reaction (PCR) was used to detect carbapemase genes. CRE colonization was detected in 19.4% of patients at admission and 18.8% during follow-up, showing no significant change ( p = 0.65). CP-CRE colonization was increased from 10.3% at admission to 16.4% ( p = 0.03) during follow-up. The most frequently identified genes were blaNDM (71.0%) and blaOXA-48 (53.0%) at admission. These genes were detected in (74.1%) and (48.1%) during follow-up, respectively. A substantial burden of CRE and CP-CRE colonization was found, with a high persistence rate. Screening high-risk patients and strengthening infection prevention measures are urgently needed.
Background: The consistency of GeneXpert and Cobas RT-PCR assays for detecting SARS-CoV-2 in pooled versus individual samples remains uncertain. Sample pooling combines multiple patient samples into a single test reaction to increase efficiency. Only one study in Ethiopia has evaluated pooling performance for SARS-CoV-2 detection, but it failed to directly compare these two widely used diagnostic tests. Purpose: This study evaluated the performance of the Cepheid Xpert® Xpress (Xpert) and Roche Cobas® (Cobas) SARS-CoV-2 assays for SARS-CoV-2 detection in pooled nasopharyngeal swab samples. Patients and Methods: The study used a cross-sectional study design on 50 confirmed SARS-CoV-2-positive samples grouped by their Cycle Threshold (CT) values. These samples were pooled with SARS-CoV-2-negative samples and tested using both assays. A total of 200 pooled samples were tested. Results: Of the 200 poled samples tested, 91.0% and 81.0% tested positive with Xpert and Cobas, respectively, with an overall agreement of 89% (κ=0.552). Strong correlation was observed between the CT values of the initial individual samples and the pooled samples for both assays. In pool-4 and pool-6, the Xpert assay detected 94.0% of positives, while Cobas assay detected 82.0%. Overall, 80.5% of pooled samples were positive and 8.5% were negative with both assays (overall concordance of 89.0%), Percent Positive Agreement of 93.6%, and Negative Agreement of 60.7%. Conclusion: Overall, these findings suggest that implementing sample pooling can be particularly beneficial in low-resource settings where testing resources are limited, enabling an increase in overall testing capacity. Xpert assay performed effectively for pooling up to six samples, whereas the Cobas assay showed reduced sensitivity, especially with low viral loads. This implies that pooling of nasopharyngeal samples from asymptomatic individuals may be missed by the Cobas assay, underscoring the importance of considering pool size, viral load and assay choices when implementing pooled SARS-CoV-2 testing.
1 June 2025 in Journal of Medical Microbiology and Infectious Diseases
Introduction: Shiga toxin-producing Escherichia coli (STEC) is a major cause of pediatric diarrhea globally, yet its burden, molecular characteristics, and antibiotic resistance patterns remain underexplored in low-resource settings like Ethiopia. This study aimed to assess the molecular detection and antibiotic susceptibility pattern of STEC among children with diarrhea in Ethiopia. Methods: ...